Scarica l'app Stockscreener
35.42
1.09%
-0.39
Agios Pharmaceuticals Inc Azioni (AGIO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
15.29%
8.189
|
7.103 | 7.399 | 6.712 | 5.609 |
| Cost Of Revenue |
7.00%
0.627
|
0.586 | 0.633 | 1.108 | 0.554 |
| Gross Profit |
16.03%
7.562
|
6.517 | 6.766 | 5.604 | 5.055 |
Operating Expenses
|
11.67%
99.63
|
112.79 | 107.66 | 99.30 | 95.67 |
| Benefits Costs and Expenses |
35.52%
100.26
|
73.98 | 108.30 | 100.41 | 96.22 |
| Costs And Expenses |
11.57%
100.26
|
113.38 | 108.30 | 100.41 | 96.22 |
| Operating Income/Loss |
13.37%
-92.07
|
-106.28 | -100.90 | -93.70 | -90.61 |
| Income/Loss From Continuing Operations Before Tax |
37.67%
-92.07
|
-66.88 | -100.90 | -83.81 | -81.02 |
| Income/Loss From Continuing Operations After Tax |
15.00%
-81.55
|
-95.94 | -91.32 | -83.81 | -81.02 |
|
Net Income/Loss
|
15.00%
-81.55
|
-95.94 | -91.32 | -83.81 | -81.02 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
61,373%
56.38
|
0.0917 | 55.80 | 55.60 | 55.27 |
| Diluted Average Shares |
61,373%
56.38
|
0.0917 | 55.80 | 55.60 | 55.27 |
| Basic Earnings Per Share |
15.70%
-1.45
|
-1.72 | -1.64 | -1.51 | -1.47 |
| Diluted Earnings Per Share |
15.70%
-1.45
|
-1.72 | -1.64 | -1.51 | -1.47 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):